NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 110 filers reported holding NGM BIOPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $292,496 | -52.3% | 273,361 | +15.5% | 0.00% | – |
Q2 2023 | $613,147 | -21.2% | 236,736 | +24.1% | 0.00% | – |
Q1 2023 | $778,476 | -59.2% | 190,803 | -49.7% | 0.00% | – |
Q4 2022 | $1,905,883 | -56.3% | 379,658 | +13.8% | 0.00% | -100.0% |
Q3 2022 | $4,364,000 | +97.6% | 333,639 | +93.7% | 0.00% | – |
Q2 2022 | $2,208,000 | -11.7% | 172,206 | +5.1% | 0.00% | -100.0% |
Q1 2022 | $2,500,000 | -31.7% | 163,918 | -20.7% | 0.00% | 0.0% |
Q4 2021 | $3,663,000 | -30.7% | 206,814 | -17.8% | 0.00% | 0.0% |
Q3 2021 | $5,286,000 | +363.7% | 251,485 | +334.9% | 0.00% | – |
Q2 2021 | $1,140,000 | -23.7% | 57,823 | +12.5% | 0.00% | – |
Q1 2021 | $1,494,000 | +2.8% | 51,381 | +7.0% | 0.00% | – |
Q4 2020 | $1,454,000 | +72.1% | 48,025 | -9.6% | 0.00% | – |
Q3 2020 | $845,000 | -29.2% | 53,122 | -12.0% | 0.00% | – |
Q2 2020 | $1,193,000 | +117.3% | 60,396 | +35.6% | 0.00% | – |
Q1 2020 | $549,000 | -65.7% | 44,533 | -48.5% | 0.00% | – |
Q4 2019 | $1,600,000 | +111.9% | 86,519 | +58.7% | 0.00% | – |
Q3 2019 | $755,000 | -8.3% | 54,512 | -3.0% | 0.00% | – |
Q2 2019 | $823,000 | – | 56,203 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 18,136,735 | $237,228,000 | 52.50% |
Ponoi II Management, LLC | 1,298,908 | $16,990,000 | 44.41% |
Ponoi Management, LLC | 1,298,908 | $16,990,000 | 23.20% |
Euclidean Capital LLC | 746,674 | $9,766,000 | 9.07% |
StepStone Group LP | 1,573,357 | $20,580,000 | 2.93% |
Logos Global Management LP | 850,000 | $11,118,000 | 1.37% |
First Light Asset Management, LLC | 955,505 | $12,498,000 | 1.26% |
GREAT POINT PARTNERS LLC | 316,256 | $4,137,000 | 1.00% |
Rubric Capital Management LP | 877,161 | $11,473,000 | 0.58% |
Avidity Partners Management LP | 1,798,100 | $23,519,000 | 0.48% |